SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 60 filers reported holding SUNESIS PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.53 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $0 | – | 700 | 0.0% | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 700 | 0.0% | 0.00% | – |
| Q4 2015 | $1,000 | 0.0% | 700 | 0.0% | 0.00% | – |
| Q3 2015 | $1,000 | 0.0% | 700 | +133.3% | 0.00% | – |
| Q2 2015 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q1 2015 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q4 2014 | $1,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 3,500,000 | $8,576,000 | 1.54% |
| GREAT POINT PARTNERS LLC | 1,038,652 | $2,545,000 | 1.12% |
| BVF INC/IL | 1,893,030 | $4,638,000 | 0.97% |
| Healthcare Value Capital, LLC | 200,000 | $490,000 | 0.53% |
| Healthcare Value Capital, LLC | 200,000 | $490,000 | 0.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,300,000 | $3,185,000 | 0.33% |
| DSC Advisors, L.P. | 225,000 | $551,000 | 0.29% |
| Perceptive Advisors | 700,000 | $1,715,000 | 0.13% |
| DSC Advisors, L.P. | 400,000 | $240,000 | 0.13% |
| Endurant Capital Management LP | 140,000 | $343,000 | 0.11% |